Error: Could not add to watchlist. X
+ Watchlist

Carnegie Fund II - Biotechnology Sub-Fund

CARBIOA:LX
26.82
EUR
As of 12:00 AM EDT 7/27/2016
Fund Type
SICAV
52Wk Range
21.28 - 40.49
1 Yr Return
-31.39%
YTD Return
-19.27%
52Wk Range
21.28 - 40.49
1 Yr Return
-30.86%
YTD Return
-19.27%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 07/27/2016)
26.82
Total Assets (m EUR) (on 06/30/2016)
22.816
Inception Date
10/10/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
ULF ARVIDSSON
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.10%
Expense Ratio
1.10%

Top Fund Holdings

Name Position Value % of Fund
24.40 k 2.14 m 9.40
25.80 k 1.90 m 8.32
8.36 k 1.78 m 7.82
27.50 k 1.49 m 6.54
19.30 k 1.46 m 6.40
14.39 k 1.00 m 4.38
5.89 k 964.86 k 4.23
2.93 k 916.40 k 4.02
8.40 k 862.86 k 3.78
17.40 k 796.90 k 3.49
Profile
Carnegie Fund II - Biotechnology Sub-Fund is an open-end investment fund registered in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in equities of companies in the biotechnology/bioscience area including companies with activities in the areas of drug discovery & delivery, therapeutics, and enabling technologies with market cap less than 500 million.
Address
c/o Carnergie Fund Services SA
P.O. BOX 1141
L-1011 Luxembourg
Luxembourg
Phone
352-40-40-30-1